Craig is awarded the Heinrich Wielend Prize, Heinrich Wieland Laureate
2020
Thanks to the results of his many years of research, Professor Craig M. Crews of Yale University
in
New Haven, Connecticut, is making innovative new medicines possible. So-called PROTACs
(proteolysis-targeting chimeras) activate a cell’s quality control system to target
disease-causing
proteins for degradation. These new active substances are intended to specifically destroy
proteins
that, until now, have been therapeutically impervious. For his ground-breaking research, Professor
Crews has been awarded the 2020 Heinrich Wieland Prize.